Functional regulation by dopamine receptors of serotonin release from the rat hippocampus: In vivo microdialysis study

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 353, Issue 6, 1996, Pages 621-629

  Matsumoto, Machiko ^a   Yoshioka, Mitsuhiro ^a   Togashi, Hiroko ^a   Ikeda, Toshiya ^a   Saito, Hideya ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

D2 receptors; In vivo microdialysis; Noradrenergic neurons; Rat hippocampus; Serotonin release

Indexed keywords

2 (N PHENYLETHYL N PROPHL)AMINO 5 HYDROXYTETRALIN; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; APOMORPHINE; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR STIMULATING AGENT; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; DOPAMINE UPTAKE INHIBITOR; FLUOXETINE; IDAZOXAN; OXIDOPAMINE; PARGYLINE; POTASSIUM ION; SEROTONIN; SULPIRIDE; TETRODOTOXIN; UNCLASSIFIED DRUG; VANOXERINE;

ANIMAL EXPERIMENT; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DRUG ANTAGONISM; HIPPOCAMPUS; INTRACEREBRAL DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MICRODIALYSIS; NONHUMAN; NORADRENERGIC NERVE; RAT; REGULATORY MECHANISM; SEROTONIN RELEASE; SEROTONINERGIC NERVE;

ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; APOMORPHINE; DOPAMINE; DOPAMINE AGONISTS; DOPAMINE UPTAKE INHIBITORS; FLUORESCEINS; FLUOXETINE; HIPPOCAMPUS; IDAZOXAN; MALE; MICRODIALYSIS; PIPERAZINES; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; TETRODOTOXIN;

EID: 0029927123     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00167181     Document Type: Article

References (51)

1. Andersen PH (1989) The dopamine uptake inhibitor GBR 12909: selectivity and molecular mechanism of action. Eur J Pharmacol 166:493-504
2. Arnt J (1985) Antistereotypic effects of dopamine D-1 and D-2 antagonists after intrastriatal injection in rats. Pharmacological and regional specificity. Naunyn-Schmiedeberg's Arch Pharmacol 330: 97-104
3. Balfour DJK, Clasper P (1982) Evidence for a presynaptic dopamine receptor in rat hippocampus. Br J Pharmacol 76:292
4. Balfour DJK, Iyaniwura TT (1985) An investigation of amphetamine-induced release of 5-HT from rat hippocampal slices. Eur J Pharmacol 109:395-399
5. Baraban JM, Aghajanian GK (1980) Suppression of firing activity of 5-HT neurons in the dorsal raphe by alpha-adrenoceptor antagonists. Neuropharmacology 19:355-363
6. Baraban JM, Aghajanian GK (1981) Noradrenergic innervation of serotonergic neurons in the dorsal raphé: demonstration by electron microscopic autoradiography. Brain Res 204:1-11
7. 3H]-serotonin from the rat substantia nigra. Naunyn-Schmiedeberg's Arch Pharmacol 335:502-507
8. Benloucif S, Galloway M P (1991) Facilitation of dopamine release in vivo by serotonin agonists: studies with microdialysis . Eur J Pharmacol 200:1-8
9. Bishoff S, Scatton B, Korf J (1979) Biochemical evidence for a transmitter role of dopamine in the rat hippocampus. Brain Res 165:161-165
10. Cedarbaum JM, Aghajanian GK (1976) Noradrenergic neurons of the locus coeruleus: Inhibition by epinephrine and activation by the α-antagonist piperoxane. Brain Res 112:413-419
11. Cheng CHK, Costall B, Ge J, Naylor RJ (1993) The profiles of interaction of yohimbine with anxiolytic and putative anxiolytic agents to modify 5-HT release in the frontal cortex of freely-moving rats. Br J Pharmacol 110:1079-1084
12. Chesselet M-F (1984) Presynaptic regulation of neurotransmitter release in the brain. Neuroscience 12:347-375
13. Copeland RL, Aulakh CS, Bhattacharyya AK, Pradhan SN (1980) Behavioural depression and its neurochemical correlates at high doses of d-amphetamine in rats. Neuropharmacology 19: 1027-1030
14. Damsma G, De Boer P, Westerink BHC, Fibiger HC (1990) Dopaminergic regulation of striatal cholonergic interneurons. Naunyn-Schmiedeberg's Arch Pharmacol 342:523-527
15. De Boer P, Damsma G, Schram Q, Stoof JC, Zaagsma J, Westerink BHC (1992) The effect of intrastriatal application of directly and indirectly acting dopamine agonists and antagonists on the in vivo release of acetylcholine measured by brain microdialysis. Naunyn-Schmiedeberg's Arch Pharmacol 345:144-152
16. 2-adrenoceptor antagonist Org 3770 enhances serotonin transmission in vivo. Eur J Pharmacol 253:R5-R6
17. Dewey SL, Smith GS, Logan J, Alexoff D, Ding Y-S, King P, Pappas N, Brodie JD, Ashby Jr CR (1995) Serotonergic modulation of striatal dopamine measured with positron emission tomography (PET) and in vivo microdialysis. J Neuroscience 15:821-829
18. 2 receptor-mediated regulation of serotonin extracellular concentration in the dorsal raphe nucleus of freely moving rats. J Neurochem 61:772-775
19. Ferré S, Cortés R, Artigas F (1994) Dopaminergic regulation of the serotonergic raphe-striatal pathway: microdialysis studies in freely moving rats. J Neurosci 14:4839-4846
20. Feuerstein TJ, Hertting G, Jackisch R (1985) Endogenous noradrenaline as modulator of hippocampal serotonin (5-HT) release. Naunyn-Schmiedeberg's Arch Pharmacol 329:216-221
21. 2-adrenoceptors on serotoninergic nerve endings in human and rat neocortex. J Neurochem 61:474-480
22. 2-Adrenoceptor mediated inhibition of the release of radiolabelled 5-hydroxytryptamine and noradrenaline from slices of the dorsal region of the rat brain. Naunyn-Schmiedeberg's Arch Pharmacol 337:255-260
23. Galzin A-M, Langer SZ (1985) Inhibition by 5,6-dihydroxy-2-dimethylaminotetralin (M7) of noradrenergic neurtransmission in the rabbit hypothalamus: role of α-2 adrenoceptors and of dopamine receptors. J Pharmacol Exp Ther 233:459-465
24. Galzin A-M, Dubocovich ML, Langer SZ (1982) Presynaptic inhibition by dopamine receptor agonists of noradrenergic neurotransmission in the rabbit hypothalamus. J Pharmacol Exp Ther 221:461-471
25. Göthert M, Schlicker E (1991) Regulation of serotonin release in the central nervous systems by presynaptic heteroreceptors. In: Feigernbaum J, Hanani M (eds) A handbook vol 2. Freund, Tel Aviv, pp 845-876
26. Göthert M, Schlicker E, Köstermann F (1983) Relationship between transmitter uptake inhibition and effects of α-adrenoceptor agonists on serotonin and noradrenaline release in the rat brain. Naunyn-Schmiedeberg's Arch Pharmacol 322:121-128
27. Heikkila RE, Manzino L (1984) Behavioral properties of GBR 12909, GBR 13069 and GBR 13098: Specific inhibitors of dopamine uptake. Eur J Pharmacol 103:241-248
28. Herve DH, Pickel VM, Joh TH, Beaudet A (1987) Serotonin axon terminals in the ventral tegmental area of the rat: fine structure and synaptic input to dopaminergic neurons. Brain Res 435:71-83
29. Imperato A, Di Chiara G (1988) Effects of locally applied D-1 and D-2 receptor agonists and antagonists studied with brain dialysis. Eur J Pharmacol 156:385-393
30. Iorio LC, Barnett A, Leitz FH, Houser VP, Korduba CA (1983) SCH 23390, a potential benzazepine antipsychotic with unique interaction on dopaminergic systems. J Pharmacol Exp Ther 226:462-468
31. Ishikawa K, Ott T, McGaugh JL (1982) Evidence for dopamine as a transmitter in dorsal hippocampus. Brain Res 232:222-226
32. Jackish R, Werle E, Hertting G (1984) Identification of mechanisms involved in the modulation of release of noradrenaline in the hippocampus of the rabbit in vitro. Neuropharmacology 23:1363-1371
33. Jackisch R, Moll S, Feuerstein J, Hertting G (1985) Dopaminergic modulation of hippocampal noradrenaline release. Naunyn-Schmiedeberg's Arch Pharmacol 330:105-113
34. 3H-5HT from rat nigral slices. Biochem Pharmacol 34:2655-2662
35. Langer SZ (1981) Presynaptic regulation of the release of catecholamines. Pharmacol Rev 32:337-362
36. Matsumoto M, Togashi H, Yoshioka M, Morii K, Hirokami M, Tochihara M, Ikeda T, Saito Y, Saito H (1991) Significant correlation between cerebrospinal fluid and brain levels of norepinepherin, serotonin and acetylcholine in anesthetized rats. Life Sci 48:823-829
37. Misu Y, Goshima Y, Ueda H, Kubo T (1985) Presynaptic inhibitory dopamine receptors on noradrenergic nerve terminals: analysis of biphasic actions of dopamine and apomorphine on the release of endogenous norepinephrine in rat hypothalamic slices. J Pharmacol Exp Ther 235:771-777
38. 2-adrenoceptors on 5-hydroxytryptamine terminals in the rat hippocampus. Naunyn-Schmiedeberg's Arch Pharmacol 347:266-272
39. Parsons LH, Justice Jr JB (1993) Perfusate serotonin increases extracellular dopamine in the nucleus accumbens as measured by in vivo microdialysis. Brain Res 606:195-199
40. Pickel VM, Joh TH, Reis D (1977) A serotonergic innervation of noradrenergic neurons in locus coeruleus. Demonstration by immunocytochemical localization of the transmitter specific enzymes tyrosine and tryptophan hydroxylase. Brain Res 131: 197-214
41. Prisco S, Pagannone S, Esposito E (1994) Serotonin-dopamine interaction in the rat ventral tegmental area: An electrophysiological study in vivo. J Pharmacol Exp Ther 271:83-90
42. 3H-5-hydroxytryptamine from rat substantia nigra in vitro. Naunyn-Schmiedeberg's Arch Pharmacol 304:271-275
43. 2-receptor agonist carmoxirole (EMD 45609) on noradrenergic and purinergic neurotransmission in rat isolated kidney. Naunyn-Schmiedeberg's Arch Pharmacol 345:300-308
44. Scatton B, Simon H, Moal ML, Bishoff S (1980) Origin of dopaminergic innervation of the rat hippocampal formation. Neurosci Lett 18: 125-131
45. 2 receptor binding sites for agonists. A tetrahedral model. Mol Pharmacol 28:391-399
46. Sloviter RS, Drust EG, Connor JD (1978) Evidence that serotonin mediates some behavioural effects of amphetamine. J Pharmacol Exp Ther 206:348-352
47. Starke K, Göthert M, Kilbinger H (1989) Modulation of neurotransmitter release by presynaptic autoreceptors. Physiol Rev 69: 864-989
48. Stoof JC, Kebabian JW (1984) Two dopamine receptors: Biochemistry, physiology and pharmacology. Life Sci 35:2281-2296
49. Verney C, Baulac M, Berger B, Alvarez C, Vigney A, Helle KB (1985) Morphological evidence for a dopaminergic terminal field in the hippocampal formation of young and adult rat. Neuroscience 14:1039-1052
50. Xu K, Näveri L, Frerichs KU, Hallenbeck JM, Feuerstein G, Davis JN, Sirén A-L (1993) Extracellular catecholamine levels in rat hippocampus after a selective alpha-2 adrenoceptor antagonist or a selective dopamine uptake inhibitor: evidence for dopamine release from local dopaminergic nerve terminals. J Pharmacol Exp Ther 267:211-217
51. Zetterström T, Sharp T, Ungerstedt U (1986) Effect of dopamine D-1 and D-2 receptor selective drugs on dopamine release and metabolism in rat striatum in vivo. Naunyn-Schmiedeberg's Arch Pharmacol 334:117-124